Cargando…
Long-term experience in the treatment of α(1)-antitrypsin deficiency: 25 years of augmentation therapy
Although it is often under-recognised, α(1)-antitrypsin deficiency (AATD) represents one of the most common genetic respiratory disorders worldwide. Since the publication of studies in the late 1980s, which demonstrated that plasma-derived augmentation therapy with intravenous α(1)-antitrypsin (AAT)...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487776/ https://www.ncbi.nlm.nih.gov/pubmed/25726554 http://dx.doi.org/10.1183/09059180.10010714 |